Medium materiality5/10
10x Genomics price target raised to $70 from $40 at Morgan Stanley
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised; current price 78.95; price declined since signal (-7.4).
- Target $70; price $78.95; Morgan Stanley
Key facts
- 01
Target: $70
- 02
Posted price: $78.95
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.